Table 3.
Mann–Whitney Unpaired Tests and Kruskal–Wallis Analysis of Variance for All Nonreticular Pseudodrusen Participants with AREDS Step Grading at Baseline on Standard 5° Testing Protocol (82% Focal Bleach, Test Spot at 5°) Comparing Participants Who Had No Change, Decreased, or Increased AREDS Step at 4 Years
| Decrease or No Change in AREDS Step | Increase in AREDS Step (1 Step) | Increase in AREDS Step (≥2 Steps) | Transitioned to SDD | |
|---|---|---|---|---|
|
| ||||
| No. | 37 | 15 | 7 | 5 |
| Median slope† (IQR), min/yr | 0.28 (0.07–1.2) | 0.69 (0.16–1.8) | 0.62 (0.29–1.4) | 2.7 (2.2–3.7) |
| Mean slope† (SD), min/yr | 0.60 (0.71) | 1.0 (1.2) | 0.85 (0.55) | 2.9 (0.80) |
| Mann–Whitney P value‡ | 0.24 | 0.17 | <0.0001* | |
| <0.0001§ | ||||
| Kruskal–Wallis analysis of variance P value | 0.27∥ | 0.0027*,¶ | ||
AREDS = Age-Related Eye Disease Study; IQR = interquartile range; RIT = rod intercept time; SD = standard deviation; SDD = subretinal drusenoid deposits.
Statistically significant at P value < 0.05.
Slope RIT = linear regression of RIT values (minimum 5 data points).
Compared with control group defined as eyes with a decrease or no change in AREDS step.
Eyes that do not transition to SDD (decrease or no change in AREDS step + increase in AREDS step [1 step] + increase in AREDS step [≥2 steps]) compared with eyes with transition to SDD.
Comparing decrease or no change in AREDS step versus increase in AREDS step (1 step) versus increase in AREDS step (≥ 2 steps).
Comparing decrease or no change in AREDS step versus increase in AREDS step (1 step) versus increase in AREDS step (≥ 2 steps) versus transition to SDD.